Analyst Conference Summaries

Biotechnology Investor Aids

MiNK Therepeutics

conference date: August 9, 2022 @ 8:00 AM Pacific Time

MiNK Therapeutics a Bargain for Cell Therapies [June 23, 2022 at Seeking Alpha]

Q1 2022
Press Release
Q2 2022
May 10, 2022 Aug. 9, 2022    

MiNK Therapeutics (INKT) is a clinical-stage biotechnology company specializing in cell therapies for cancers and immunological diseases.

MiNK Therapeutics web site



More Analyst Conference Pages:


Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2022 William P. Meyers